Crossmark

Comparison of outcomes and side effects for neoadjuvant chemotherapy with weekly cisplatin and paclitaxel followed by chemoradiation vs. chemoradiation alone in stage IIB–IVA cervical cancer: study protocol for a randomized controlled trial

Crossref DOI link: https://doi.org/10.1186/s13063-021-05986-z

Published Online: 2022-01-10

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Jing

Liu, Hua

Li, Ya

Li, Jian

Shen, Lifei

Long, Wenqing

Yang, Chenmin

Xu, Haoping

Xi, Wenqi

Cai, Rong

Feng, Weiwei
Funding

Funding for this research was provided by:

Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support (20172003)

Natural Science Foundation of Shanghai Science and Technology Commission (19411961000)
License Information

Text and Data Mining valid from 2022-01-10

Version of Record valid from 2022-01-10
More Information

Article History

Received: 17 November 2020

Accepted: 27 December 2021

First Online: 10 January 2022

Declarations

:

: The study was approved by the Shanghai Jiaotong University School of Medicine Ruijin Hospital Ethics Committee (2018-239). Written, informed consent to participate will be obtained from all participants.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below